Woodline Partners’s ImageneBio Inc IMA Stock Holding History

Woodline Partners’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,471	Closed	-$3.21M	–	608
2021 Q1	$3.21M	Buy	+9,471	New	+$3.24M	0.07%	240

Other funds holding IMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners's IMA Position: Q2 2021 in Review

Woodline Partners sold out of ImageneBio Inc (IMA) in Q2 2021, closing a stake of 9,471 shares — an estimated $3.21M sold.

Woodline Partners first reported a position in IMA in Q1 2021 and held it in 1 quarter. The position peaked at $3.21M in Q1 2021. 42 funds tracked by Wall St. Rank hold IMA as of Q2 2021.

Woodline Partners reported no remaining ImageneBio Inc position as of Q2 2021 after selling out during the quarter.
Woodline Partners sold 9,471 ImageneBio Inc shares in Q2 2021, an estimated $3.21M.
Woodline Partners first reported a position in ImageneBio Inc in Q1 2021 and held it in 1 quarter.
Woodline Partners's ImageneBio Inc position peaked at $3.21M in Q1 2021.
42 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2021.

Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.